SPY333.94-0.63 -0.19%
DIA276.49+1.87 0.68%
IXIC10,897.76-113.22 -1.03%

Barclays Maintains Overweight on CVS Health, Raises Price Target to $79

Barclays maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $75 to $79.

Benzinga · -

Barclays maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $75 to $79.